CLINICAL_TRIALS
withdrawal
· 2015-09-10
Clinical Trial Update: Levothyroxine in Pregnant SLE Patients [Phase 4]
Summary
A Phase 4 clinical trial evaluating levothyroxine in pregnant patients with systemic lupus erythematosus has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: WITHDRAWN